Cytometry

IMMUNI T offers the full range of immunological services to support the drug development process from discovery to post-marketing.

IMMUNI T has developed significant expertise through experience in performing both standard and custom immuno-detection/diagnostic assays and assay validations.

IMMUNI T has certified state of the art equipment at its disposal such as multi-laser flow cytometers, radioactive plate counters, ligand binding platforms (ELISA, Luminex and MSD-ECL) and BSL2 (P2) cell culture facility with an expertise at working with primary material.

Our facility is located in Montreal, one of the major immunology hub in North America. For specific research projects, we also benefit from pro-active partnering resources with 4 universities and all major university hospitals within a 2 kilometers radius, with high technology equipment platforms and competent human resources, comprising Concordia University, McGill University, Université de Montréal and Université du Québec à Montréal.

Lower your risk, increase your value.   Smart up your business and work with              !
Luc Villeneuve, PhD, CEO

IMMUNI T is a contract research organization (CRO) providing high quality services in immunology and immunotoxicology with a core expertise in functional cell-based assays, flow cytometry and ligand-binding bioanalysis.

IMMUNI T performs cytotoxicty and other cell-based assays; ex vivo immunogenicity assays (cytokine release, proliferation), immunological assays based on flow cytometry analysis for determination of cell function, ligand-binding bioanalysis services for the quantification and detection of analytes including peptides, proteins or nucleic acids; as well as customization, development and validation of assays for pre-clinical and clinical sample analysis in a GLP-compliant environment.

IMMUNI T covers all your needs for biologics (peptides, proteins, therapeutic antibodies, biosimilars, vaccines and oligonucleotide-based therapeutics) in all phases of drug development programs.

Who We Are

High quality services in immunology: immuno-diagnostic/assays, cytokine detection, receptor binding, cell phenotyping, immunogenecity assessment and prediction, cell line characterization, ELISA and HL-ELISA.

Contract research services in:

  • Immuno-oncology

  • Inflammation

  • Hematology and hemato-oncology

  • Biotherapeutic characterization

  • Biosimilar qualification

  • Vaccine efficacy and safety

  • Autoimmunity

  • Allergy

  • Nanomedicine

Custom assay development and validation including primary and cell-line based assays for immuno-detection and diagnostic assays.

Special support for immunotherapeutics, immuno-modulation therapy and environmental immunotoxicology.

The following brochure provides a summary of the company and of the services IMMUNI T offers.​

Our Services

Zymeworks highly recommends IMMUNI T as a scientific CRO. IMMUNI T currently provides preclinical in vitro support for a variety of our bispecific and ADC programs and their technical expertise in the timely execution of complex experiments has been invaluable. They are a professional and highly organized team and their services would be an asset to any organization.

Candice Madalena, Senior Project Manager, Zymeworks Inc.

I have contracted IMMUNI T for several of our in vivo and ex vivo immunological studies over the years. I have always been very impressed and satisfied with their scientific knowledge, ability to accommodate our specific requests in a timely fashion and work ethics. I’m a big fan of their team and I strongly recommend IMMUNI T to anyone looking for a CRO with extensive immunological experience. They are the perfect partner for a small company like ours relying on external expertise.

Eric Zanelli, PhD
President and Scientific Founder Déclion Holdings LLC
Customer Satisfaction

May 01, 2020

ImmunoSpot S6 FluoroCore analyzers

IMMUNI T acquired two new ImmunoSpot S6 FluoroCore analyzers (CTL Analysers, LLC), with 2-3 color Analyzers capable of performing both visible and fluorescent analyses to expand its capabilities in cell-based analysis.

The addition of these instruments provide more flexibility in performing cell-based assays and activated cell population quantification.

Moving forward, IMMUNI T offers multiplex analysis including the qualified and validated ELISPOT for regulated immune monitoring studies as well as bacterial, yeast, stem cell, tumor colony counting and other clonogenic assays.

October 22, 2019

GOOD LABORATORY PRACTICE (GLP) RECOGNITION

Immuni T is proud to announce that we have been recognized by the Standards Council of Canada (SCC) as being compliant with the OECD Principles of Good Laboratory Practice (GLP). GLP regulates the conduct of all non-clinical safety studies worldwide; the SCC is the only monitoring body that grants GLP recognition in Canada.

GLP recognition means that Immuni T has the infrastructure, personnel, and knowledge to conduct studies that produce valid and high quality data intended for submission to Health Canada, the US FDA, and regulatory bodies around the world (IND or CTA). In the drug development process, these bodies use this data to decide whether clinical studies in humans can proceed.

Immuni T develops, validates, and executes GLP-compliant toxicity, anti-drug antibody (ADA), and other assays, to support non-clinical safety studies.

Immuni T is a Montreal-based contract research organization (CRO) that offers immunology services on flow cytometry, ligand binding, and cell-based platforms.

To learn more about Immuni T's GLP services, contact us at bud@immunit.com or +1-514-545-3097 extension 102.

November 07, 2018

Is Your Biotherapeutic Immunomodulatory? How to Use Immunoassays to Get the Right Answer

Topics covered in this webinar were:

  • Why assessment of immune-based therapies’ mechanism of action is pivotal to their further application

  • About the physiological relevance of ex vivo immuno-modulation assays and appropriate data interpretation

  • How having better knowledge of the immune characteristics of the drug at an early stage of development will save time and money and will allow better preclinical and clinical desig

October 09, 2018

Farideh Nourian, Ph.D Joins ImmuniT's Team

Immuni T proudly announces the appointment of Dr. Farideh Nourian as the new member of board of directors. Dr. Nourian will serve as Director of Business Development and brings a wealth of experience and expertise that were gained from twenty years of working as assistant professor in academia and Principal Scientist at CRO, Biotech and Pharmaceutical companies in North America such as Kiadis Pharma, Charles River Laboratories (CRL) and Algorithme Pharma. Most recently, Dr. Nourian has been involved in a string of successful consulting for Pliant Pharmaceutics in USA.

 

Dr. Nourian holds B.Sc and M.Sc in Biology and Medical Microbiology, respectively and obtained her Ph.D in Biotechnology/Food Science from McGill University. She has two post-doctoral training in the fields of cell and molecular biology at McGill University and Microbiology at Agriculture and Agri-Food Canada.

 

Immuni T is pleased that she accepted this appointment and know she will represent the company well and will contribute much to its success.

October 03, 2018

Is Your Molecule Immunogenic? How to Use Immunoassays to Get the Right Answer

Immuni T organized a live webinar about biotherapeutics and immunogenicity entiteled: Is Your Molecule Immunogenic? How to Use Immunoassays to Get the Right Answer :

Topics covered in this webinar were:

  • Why assessment of immune-based therapies’ mechanism of action is pivotal to their further application

  • About the physiological relevance of ex vivo immuno-modulation assays and appropriate data interpretation

  • How having better knowledge of the immune characteristics of the drug at an early stage of development will save time and money and will allow better preclinical and clinical design  

1 / 1

Please reload

CONTACT US

CRO services

BeLPT samples

Address

5th floor, suite SB-5180

141 President-Kennedy Avenue , 

Montreal, Quebec, Canada H2X-1Y4

P.O.BOX #3

Telephone : +1(514) 545 3097

Fax : +1(514) 545 3064